Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Procenta
- Development stage
- Unknown
- Lead developer
- Lucina
- Administration
- Topical, Surgical Application
01
Overview
Procenta is a sterile, decellularized, and dehydrated human placental disc allograft developed by Lucina BioSciences. It is derived from donated human gestational tissue and is processed to maintain the structural integrity of the extracellular matrix (ECM) while removing cellular components to minimize immunogenicity. Procenta is primarily indicated for the management of Placenta Accreta Spectrum (PAS), a serious pregnancy complication where the placenta attaches too deeply to the uterine wall, often leading to life-threatening hemorrhage. It functions as a biological scaffold that provides structural support and a microenvironment conducive to tissue repair and regeneration during surgical intervention for PAS. The FDA has granted Procenta Orphan Drug and Fast Track designations for this indication, reflecting its potential to address a significant unmet medical need in maternal health.
- Brand names
- Procenta
- Other names
- decellularized human placental dischuman placental disc allograft
Beyond the preview
Go deeper on Procenta.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Procenta.